Abstract
Parkinson disease is a heterogeneous disease with rapidly and slowly progressive forms. Treatment involves pharmacologic approaches (typically with levodopa preparations prescribed with or without other medications) and nonpharmacologic approaches (such as exercise and physical, occupational, and speech therapies). Approaches such as deep brain stimulation and treatment with levodopa-carbidopa enteral suspension can help individuals with medication-resistant tremor, worsening symptoms when the medication wears off, and dyskinesias.
Keywords
Affiliated Institutions
Related Publications
Clinically Atypical Expression of Pathologically Typical Lewy-Body Parkinsonism
Six patients autopsied by the neuropathology service at UMDNJ—Robert Wood Johnson Medical School between 1985 and 1988 had pathologically typical Lewy-body Parkinson's disease (...
Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease
To examine the natural history and pathogenesis of parkinsonism in Alzheimer's disease, 44 subjects with clearly established senile dementia of the Alzheimer type were studied d...
Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients.
Two patients with levodopa-responsive Parkinson's syndrome had numerous cortical and striatal senile plaques and some neurofibrillary tangles at necropsy. In addition neurons in...
Synucleinopathies
The synucleinopathies are a diverse group of neurodegenerative disorders that share a common pathologic lesion composed of aggregates of insoluble alpha-synuclein protein in sel...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 323
- Issue
- 6
- Pages
- 548-548
- Citations
- 2518
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1001/jama.2019.22360